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 Rheumatoid arthritis is characterised by symptoms and functional limitations that can 
interfere with regular engagement in physical activity.  It is also associated with 
systemic manifestations, most notably cardiovascular disease. 
 The cost of rheumatoid arthritis is proportionately higher than this of other non-
communicable diseases. 
 Physical activity and exercise are safe and effective interventions to ameliorate 
symptoms and systemic manifestations of rheumatoid arthritis. 
 Implementation of physical activity interventions in clinical practice remains extremely 
limited; it should be led – in a pragmatic manner – by rheumatology healthcare 





Rheumatoid arthritis is characterised by functional disability, pain, fatigue and body 
composition alterations that can further impact upon physical function.  It is also associated 
with systemic manifestations, most notably an increased risk for cardiovascular disease. There 
is strong evidence to suggest that increasing physical activity and/or exercise can 
simultaneously improve symptoms and reduce the impact of systemic manifestations of RA. 
However, implementation of interventions to facilitate increased physical activity and/or 
exercise within routine clinical practice is slow, due to patient-specific and healthcare 
professional-related barriers but also due to lack of relevant infrastructure and provision. We 
review the evidence supporting the physiological adaptations and beneficial effects occurring 
as a result of increased physical activity and/or exercise in RA and propose an implementation 
model for facilitating the long-term engagement of RA patients. We propose that 
implementation should be led, in a pragmatic manner, by rheumatology healthcare practitioners 
and supported by social innovation.      
1.0 Introduction 
 
Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease, typically presenting 
as symmetrical polyarthritis of proximal small and other synovial joints. It affects 
approximately 1% of the adult general population and it is accompanied by symptoms – such 
as pain, stiffness, swelling and fatigue – that may have debilitating effects on the functional 
ability and quality of life of affected patients. In addition, RA is accompanied by systemic 
manifestations, most notably an increased risk for cardiovascular disease (CVD) as well as 
detrimental changes in body composition, favouring increased fat mass deposition and reduced 
muscle mass [a condition termed “rheumatoid cachexia”(1)]. These, in turn, further deteriorate 
function and the ability to perform daily tasks (1). Therefore, it is not surprising that almost a 
third of RA patients become unemployed as a result of their condition (2) and have 10 times 
the work disability rate compared to the general population (3). The introduction of early, 
intensive anti-inflammatory / immuno-modulating treatments and strategies involving  
conventional synthetic and biologic disease-modifying anti-rheumatic drugs (DMARDs) and 
more recently newer small molecules, has significantly improved the outcome of these patients 
but, thus far, without substantial changes to their employment ability and with a significant 
increase (around 300%) of the direct healthcare costs (3). As such, identifying beneficial, 
sustainable and cost-effective interventions that may alleviate the burden of RA for the 
individual, healthcare services and society as a whole should be adopted and implemented as 
part of routine clinical practice. 
 
An intervention that can improve both disease-related as well as systemic manifestations in 
RA, reducing at the same time the overall cost associated with the disease, is an increase in 
physical activity. Physical activity, is any bodily movement that increases energy expenditure 
above resting levels, such as walking and gardening. Exercise on the other hand, is a mode of 
physical activity that is planned, structured and repetitive, such as swimming three times per 
week.  
 
Over the last two decades, good quality evidence has accumulated, clearly demonstrating that 
increasing physical activity is a behavior that can significantly improve many different disease-
related (e.g. fatigue, functional disability, inflammation) and systemic outcomes (e.g. CVD risk 
and body composition) as well as impact beneficially on RA costs. Specifically, in terms of 
cost, increased physical activity in RA associates with a reduced number of hospital admissions 
and days of hospitalization (4); this is also confirmed in patients with CVD where increasing 
physical activity through cardiac rehabilitation, is both an effective and cost-effective 
intervention for reducing national healthcare costs (5). For health outcomes in RA, we and 
others have shown in systematic reviews (two published by the Cochrane Collaboration), that 
increased physical activity results in significant improvements in functional ability, 
cardiorespiratory fitness and strength (6-8), cardiovascular health (9) and fatigue (10). 
Moreover, randomized and controlled clinical trials consistently demonstrate significant 
reductions of radiological damage in small and large joints, as a result of increased levels of 
physical activity participation (11-14), as well as reduced CVD risk and beneficial body 
composition changes that can reverse rheumatoid cachexia (14-17). It is important to note that, 
increasing physical activity or engaging in different types of exercise, even in high-intensity 
exercise, is safe in RA with no studies reporting any adverse effects (18); in contrast, a 
sedentary lifestyle in RA can further promote the increased risk for future development of CVD 
(19-21).  
 
Despite this well-described cumulative evidence about its beneficial effects, methods to 
improve physical activity levels in patients with RA are not incorporated in routine clinical 
care. RA patients, as a result, still remain physically inactive, with activity levels well below 
those recommended (22), while their cardiorespiratory fitness – a factor that demonstrates very 
strong associations with all-cause and cardiovascular mortality (23) – is still alarmingly low 
(24).  
     
 
2.0 Physiological effects of physical activity on RA symptoms and systemic manifestations 
 
Physical activity is a stimulus that results in significant functional and structural adaptations in 
different physiological systems, that in turn, may beneficially impact on the overall RA 
symptomatology. The benefit of increasing physical activity and exercising, is that it can 
simultaneously improve different physiological mechanisms, which with regards to RA, can 
benefit two main categories of outcomes for RA sufferers: disease-related symptoms and 




2.1 Mechanisms mediating the beneficial effects of physical activity on RA symptoms  
 
2.1.1 Inflammation 
An area that has received significant research attention in the last few years, is the anti-
inflammatory effects of physical activity. Exercise, a part of physical activity, is now 
considered a major stimulus that can result in anti-inflammatory effects. Exercise can induce 
both acute and long-term beneficial reductions of the inflammatory response in a dose-
dependent manner (i.e. higher exercise intensities will result in more pronounced beneficial 
effects), via potentially different physiological mechanisms.  
 
The acute phase response depends on a vicious cycle that is based on the co-existence and 
cross-talk of pro-inflammatory cytokines, predominantly interleukins 1 and 6 (IL-1 and IL-6) 
and tumour necrosis factor alpha (TNFα). The kinetics of these inflammatory mediators, which 
are highly expressed in autoimmune diseases including RA, are different during exercise vs. 
sepsis / inflammation. Specifically, exercise-induced increases in IL-6 do not seem to promote 
an inflammatory state; instead, exercise-induced increases in IL-6 mRNA expression are 
thought to act as a trigger for increasing hepatic glucogenolysis and lipolysis, in order to 
provide more energy for the exercising muscles (25). IL-1 and TNFα remain suppressed during 
a bout of exercise, while in contrast they are highly overexpressed in sepsis and/or 
inflammation (25). In support of this, macrophage (inflammation-induced) and intramuscular 
(exercise-induced) induction of IL-6, depend on different signalling pathways. Inflammation, 
which is based on IL-6 macrophage signalling, depends on the upstream and downstream 
signalling of IL-6, induced by the activation of nuclear factor-kB (NF-kB) and necessitates the 
presence of TNFα (26). In contrast, exercise-induced overexpression of IL-6 occurs without an 
a priori overexpression of TNFα or NF-kB activation, and is regulated by an interaction 
between the nuclear factor of activated T-cells and glycogen-p38 mitogen activated protein 
kinase pathways (27).  At the same time, exercise-induced increases in IL-6 coincide with 
increases in the anti-inflammatory cytokines, IL-10, soluble TNF receptor and IL-1 receptor 
antagonist (25). Thus, an acute bout of exercise, can induce an anti-inflammatory phenotype.  
 
In the longer term, the anti-inflammatory effects of exercise are mainly based on its beneficial 
effects on body composition. Overweight and obese individuals demonstrate higher 
inflammatory load, compared to the healthy population while it has been observed that 
inflammatory processes are activated early in adiposity expansion and progression (28). 
Indeed, obesity is now considered an inflammatory condition. The most recent systematic 
review and meta-analysis on the effects of exercise vs. hypocaloric diets on adiposity, revealed 
that exercise can result in a greater loss of visceral fat in the absence of weight loss (29). 
Reducing the size of adipocytes as a result of exercise, results in lower levels of inflammation, 
even in populations with non-communicable, low-grade inflammatory diseases such as 
diabetes (30). It is therefore thought that the long-term anti-inflammatory effects of exercise 
are mainly due to reduction of the size of adipocytes.  
 
2.1.2 Functional ability and fatigue 
There is growing evidence that physical activity and/or exercise can significantly improve 
disease activity and severity in RA patients, facilitating significant improvements in their 
functional ability and quality of life. Perhaps the most comprehensive randomised controlled 
trial, the “rheumatoid arthritis patients in training” study, revealed that a two-year high 
intensity exercise program of combined aerobic and strength training significantly improved 
functional ability of the exercising RA patients vs. non exercising RA controls; at the same 
time, high-intensity exercise did not increase radiological damage in the large joints (11). These 
results are in line with other, smaller randomised controlled trials in this field (31). A 2009 
systematic review and meta-analysis of eight studies in the Cochrane Library, which 
unfortunately has not been updated since, revealed that fitness and strength are significantly 
improved as a result of exercise training in RA patients, a fact that may explain the significant 
benefits the patients experience in their functional ability (6). The same review suggests that 
exercise may also reduce pain in RA. A more recent 2012 unmbrella review of systematic 
reviews and meta-analyses (both Cochrane and non-Cochrane) revealed that the effect 
estimates for the efficacy of exercise therapy are generally smaller in RA compared to other 
musculoskeletal conditions (i.e. osteoarthritis, low back and shoulder pain and fibromyalgia) 
for improving pain and functional ability (32). Moreover, despite that RA patients may be at 
increased risk for falling, a 2010 Cochrane Collaboration systematic review concluded that no 
studies exist in the literature that address physical activity in relation to this particular outcome 
in RA (33). Finally, a 2010 meta-analysis of randomised controlled trials (10 studies with 547 
participants), concluded that resistance exercise training can improve different strength 
outcomes (isokinetic, isometric and grip strength) (8) which may have a potentially beneficial 
impact on functional ability and as a result, performance in daily tasks. However, the quality 
of the studies included in this meta-analysis was evaluated using earlier research quality tools, 
and thus, the interpretation of these findings should be treated with caution. It seems aparent 
from the above that: a) the existing meta-analysis need updating as more recent trials has been 
published from 2010 until 2019 and b) more studies are required in this field to draw definitive 
conclusions. 
 
The effects of exercise programs on fatigue have also attracted attention in recent studies, since 
fatigue is a very commonly reported and debilitating symptom of RA. The most recent meta-
analysis of five randomised controlled trials reveals that exercising for 12 weeks vs. no 
exercise, results in significant reductions in fatigue in RA patients. This is an interesting 
finding, since fatigue is reported by RA patients to be one of the main barriers for non-
participation in exercise programs (34), and poses significant questions with regards to the best 
ways to “convince” people with RA to participate and remain in an exercise programme and 




2.2 Mechanisms mediating the beneficial effects of physical activity on RA systemic 
manifestations 
 
2.2.1 Cardiovascular disease  
Physical activity has been proposed as a key intervention for reducing the most predominant 
risk factors for developing CVD, namely insulin resistance, hypertension and 
hypercholesterolemia. Recent studies confirm that these beneficial effects are also evident in 
RA. The updated European League Against Rheumatism (EULAR) guidelines acknowledge 
these issues and have updated their guidelines to recommend lifestyle change for reducing the 
CVD burden in RA, by including suggestions to increase physical activity (35).   
 
For insulin resistance, exercise enhances the translocation of the insulin-mediated glucose 
transporter type 4 (insulin regulated glucose transporter) to the sarcolemma which may result 
in increased glucose uptake in the cell, up to 24 hours post-exercise (36). This transient 
exercise-induced change in the translocation of insulin-mediated glucose transporter type 4 is 
thought to be the main mechanism resulting in a long-term improvement in glucose 
homeostasis in individuals with an insulin resistant phenotype. As such, it comes as no surprise 
that the most recent Cochrane Library meta-analysis reported that diabetics in exercise 
interventions (both aerobic and resistance training) had statistically and clinically significantly 
improved glycemic control when compared to their non-exercising counterparts (37). In RA, 
both higher physical activity and fitness (i.e. maximal oxygen uptake) levels have been 
associated with reduced insulin resistance (24, 38), although the mechanisms have not been 
studied in detail in this population.  Potentially the combination of increased physical activity 
and anti-TNFα therapy may hold great promise in improving insulin sensitivity, particularly in 
normal weight RA, since anti-TNFα therapy seems to reduce insulin resistance (39). Overall, 
insulin sensitivity is impaired with increasing body mass index in RA (40), a phenomenon that 
can be partly improved via engaging in physical activity.  
 
Elevated blood pressure is also a CVD risk factor that can be reduced by a clinically significant 
magnitude when physical activity in increased (41). Immediately post-exercise, there is a 
reduction in blood pressure thought to be caused by reduced peripheral vascular resistance (41, 
42). In the longer-term, exercise affects blood pressure via a variety of different mechanisms 
including enhanced baroreceptor sensitivity, reduced peripheral vascular resistance, improved 
endothelial function and vasodilator, such as nitric oxide bioavailability, and improved 
resistance to oxidative stress (42). Findings specifically in patients with RA are well in line 
with these, although again the mechanisms have not been specifically studied in this 
population. RA patients with higher physical activity levels as well as higher maximal oxygen 
uptake have lower blood pressure, when compared to RA patients with lower levels of physical 
activity or fitness (24, 38).  
 
Various modes of exercise also have beneficial effects on lipoprotein profiles. Exercise-
induced changes in lipid profiles are achieved in lecithin-cholesterol acyltransferase, which is 
an enzyme that converts cholesterol into cholesteryl ester, eventually facilitating synthesis of 
the anti-atherogenic high-density lipoprotein (43). Furthermore, exercise induces increases in 
lipoprotein lipase (44), another enzyme with a major role in hydrolysing triglycerides into free 
fatty acids and glycerol. With regards to the effects of exercise on the major lipoproteins 
involved in atherosclerosis, a recent review of 15 studies (13 experimental studies and two 
reviews), confirms that exercise has beneficial effects on lipid profile in both healthy 
individuals as well as those with hypercholesterolemia (45). Participating in regular exercise 
can increase high-density lipoprotein while at the same time offsetting relevant increases in 
triglycerides as well as low-density lipoprotein in atherosclerosis (45). Another meta-analysis 
of 49 randomized controlled trials in healthy men and women older than 18 years of age with 
elevated cholesterol, demonstrated that aerobic exercise improves significantly total 
cholesterol, high-density lipoprotein and triglycerides, while for low-density lipoprotein a 
beneficial non-significant trend was observed (46). A separate meta-analysis by the same group 
of authors, confirms these beneficial exercise-induced effects on lipids in women (47), 
something that may be particularly relevant in a predominantly female population such as this 
suffering from RA. Studies specifically in RA demonstrate that more physically active patients 
as well as those with higher levels of cardiorespiratory fitness have significantly better lipid 
profiles compared to those that have lower physical activity and fitness levels (24, 38), however 
again the exact mechanisms that may explain such associations in this population have not been 
studied.  
 
Several other exercise-induced effects may be of relevance in lowering CVD risk. The leading 
cause of CVD, atherosclerosis, can be beneficially managed via increasing physical activity 
and fitness levels. A key step in the evolution of atherosclerosis is the oxidization of low-
density (LDL) lipoprotein in the endothelium. Increasing cardiorespiratory fitness levels, via 
appropriately designed exercise interventions, significantly reduces oxidized LDL (48). 
Moreover, high-intensity exercise training does not enhance oxidative stress processes in RA 
patients while in the long term, three-nitrotyrosine (a biomarker of nitrogen free radical species 
modified proteins) significantly reduces, supporting the findings seen in healthy populations 
that exercise counteracts the development of oxidative stress related mechanisms (49). Finally, 
significant alterations take place, via exercise, in vascular function. Increasing shear stress due 
to exercise-induced haemodynamics, results in functional and structural changes in the 
vasculature, that help reverse CVD processes. Vascular function may be significantly impaired 
as a result of persistent inflammation in RA (50). In contrast, exercise training for three or six 
months at intensities of up to 75% of maximum heart rate can significantly improve micro- and 
macro- vascular function in RA, possibly via the effects of exercise to increase nitric oxide bio-
availability, a key mediator for the maintenance of vascular homeostasis (13, 51).        
 
2.2.2 Rheumatoid Cachexia  
Rheumatoid cachexia is a condition predominantly driven by the overexpression of TNFα [i.e. 
a similar pathway with cancer cachexia (52)] and characterised by increased resting metabolic 
demands (1, 53). This phenomenon can be further deteriorate via smoking (54). This eventually 
results in significant alterations in body composition of RA patients, characterised by increased 
fat deposition and reduced muscle mass compared to healthy age- and gender- matched adults 
(1). Indeed it has been suggested that the body mass index cut-off points for RA patients should 
be altered for overweight and obesity to 23 kg/m2 (rather than 25 kg/m2) and 28 kg/m2 (rather 
than 30 kg/m2), respectively (55). In the absence of established diagnostic criteria for 
rheumatoid cachexia, the prevalence of the syndrome ranges from 8% to 67% in the RA 
population (17), however, it has been suggested that RA patients that experience these 
detrimental body composition changes may have worse functional ability and disease 
symptoms as well as increased risk for CVD (1, 56). Blocking TNFα, via anti-TNFα 
medication, does not reverse rheumatoid cachexia up to a period of six months in either early 
or established RA patients (57, 58). However, exercise is an intervention that can significantly 
reverse these phenomena, by significantly increasing muscle mass with no adverse effects (15).  
 
A summary of the mechanisms by which physical activity can improve disease-related and 









3.0 Barriers for physical activity implementation in clinical practice 
 
Despite the well-documented benefits of physical activity and exercise on various different 
physiological mechanisms that can significantly ameliorate disease symptoms and improve the 
overall function and quality of life in RA (59), the physical activity and fitness levels of patients 
with RA remain significantly lower compared to the general population. The QUEST-RA study 
that investigated physical activity levels in RA patients from 58 sites in 21 countries revealed 
that only 13.8% of RA patients perform physical activity more than three times per week, i.e. 
the currently recommended levels (60).  
 
Given the multiple different benefits of physical activity in RA, studies have focused on 
identifying the different barriers that may hinder participation. The most recent systematic 
review in this field reveals that RA patients report as barriers factors that overlap with those 
observed in the general population, such as lack of time and cost (34). However, the majority 
of studies identify also disease-specific barriers particularly pain, fatigue and functional 
disability (34), all of which, interestingly and as already mentioned, can be significantly 
improved once patients start exercising (6, 10).  
 
The lack of physical activity and exercise in the RA population may also be due to other factors, 
predominantly influenced by rheumatology healthcare professionals. Until recently, the 
diagnosis of RA was accompanied by the advice to rest and avoid physical activity, as 
healthcare professionals feared that exercise may exacerbate disease symptoms and lead to 
further functional disability. Despite the overwhelming evidence that physical activity, even 
high-intensity exercise, is safe in RA and has no adverse effects, implementation of 
programmes aiming to enhance physical activity in routine clinical practice is still lacking. In 
line with this, RA patients report as a main barrier for their reduced participation in physical 
activity, the lack of advice and support from their managing rheumatology healthcare 
practitioners. This is confirmed by a recent review on barriers and facilitators for physical 
activity in RA as well as the most recent qualitative studies on physical activity engagement in 
RA (34, 61, 62).  
 
 
4.0 How can we implement physical activity advice in clinical practice 
 
As described above, there is convincing data at present to suggest that increasing physical 
activity can improve disease outcomes in RA, thus leading to better disease management. It is 
expected, therefore, that attempts would be made in the last decade to help implement 
programmes aiming to improve physical activity as integral parts of the overall management 
of RA, or at least that physical activity is promoted more actively within clinical practice. 
However, this is not the case.  
 
Several studies have addressed possible ways to help patients become and remain more 
physically active (63, 64). Irrespective of the outcomes of these studies, the long-term 
engagement in physical activity significantly suffers after the end of any intervention, as 
patients that previously engage with physical activity and/or exercise tend to become again 
physically inactive post intervention, which is general phenomenon in other non-
communicable diseases (65). To address this important matter, we propose a theory for 
implementation that can effectively address key barriers from both (a) the healthcare 
practitioners’ and (b) the patients’ perspectives in order to increase levels of physical activity; 
this is also based on the well- and long-known relationship between the managing 
rheumatology healthcare practitioner and the patient, a keystone in healthcare, which evidently 
promotes uptake and adherence to behaviors that can significantly improve health (66, 67). It 
is however important to note, that this implementation model, although theory and evidence-
based, remains to be appropriately tested in relevant trials as a whole or in part.  
 
4.1 Addressing healthcare practitioners’ barriers for implementing physical activity in clinical 
practice 
 
At present, unfortunately, we and others have shown that there is a lack of provision from 
official bodies – such as the British Society of Rheumatology, EULAR, Arthritis Research UK 
and others –  on physical activity advice for RA patients, as well as advice to healthcare 
professionals and commissioners on how to effectively: (a) incorporate physical activity in the 
clinical management of RA and (b) promote long-term adherence to a physically active 
lifestyle (68, 69). As such, even if individual attempts to promote and implement physical 
activity in clinical practice existed, the material to support such initiatives (e.g. instruction on 
how to implement or how to address patient’s aims in an individualized manner) are non-
existent for RA. This is surprising, since embedding physical activity into healthcare streams 
and promoting long-term adherence are now recognized priority targets by the World Health 
Organization (WHO) for the effective management of non-communicable chronic diseases, 
such as RA (70). The WHO has proposed that physical activity implementation can be achieved 
with capacity building at the level of frontline healthcare practitioners managing the patients 
(i.e. in the case of RA, rheumatologist healthcare professionals) (71). Unfortunately, a very 
low number of doctors involved in the management of RA (17%) have the confidence to 
prescribe physical activity for their patients (72), a fact revealing that relevant provision is 
probably necessary at all levels of a rheumatologist’s professional career, from undergraduate, 
through postgraduate training, to specialization and continuing professional development. In 
addition to that, information on physical activity, even when provided by the consulting 
doctors, is inconsistent at present, and there is uncertainty about how to advise RA patients on 
increasing physical activity (73) which, as previously stated, is an important barrier for the 
patients (62). 
 
For a wider implementation and scaling-up of physical activity engagement within the 
healthcare set-up, we propose that this should be led by the main healthcare practitioners 
involved in the patient’s management during routine clinical visits, in a repetitive, enabling 
and reinforcing fashion. Education about the mechanisms and benefits of physical activity on 
different health parameters is not covered extensively in the curricula of Medical Degree 
programs (74) and even less afterwards. Therefore, while “deep infrastructure” is developed at 
all levels/stages of a health practitioner’s career, perhaps a viable interim solution to address 
this problem could be expert-led e-educational capacity-building initiatives. E-learning 
education is a preferable method of learning for healthcare practitioners while collective 
evidence reveals that it can facilitate wider dissemination and up-scaling of successful practices 
(75). Capacity building of frontline healthcare professionals for incorporating physical activity 
in clinical practice is also in line with recent recommendations from the WHO and other 
national authorities, for optimizing healthcare in a sustainable manner (70). Considering the 
financial pressures on National Health Services, physical activity implementation should also 
be cost–effective, so potentially the inclusion of brief but meaningful physical activity advice 
during routine patient visits (i.e. a pragmatic approach), may be an intervention that holds great 
promise (76), but this needs to be prospectively evaluated in RA.  
 
The above suggestion, is also supported by good quality evidence. Strong evidence has 
emerged from other disease entities that when healthcare practitioners incorporate physical 
activity advice in their clinical practice, they can significantly contribute towards altering 
behaviors and help patients with other chronic non-communicable diseases to become more 
physically active. Specifically, when clinicians in primary care were trained to deliver brief (3-
4 minutes) interventions during routine patient visits, this resulted in increased levels of 
physical activity over a 2-year follow-up as well as significant improvements in 
cardiorespiratory fitness (77). In addition, the PREMIER and SMARTER trials (78, 79) 
provided strong evidence that brief lifestyle and physical activity counselling among adults 
with prehypertension or stage 1 hypertension and/or diabetes [both highly prevalent in RA (80-
82)] resulted in a significant reduction in cardiovascular risk with excellent sustainability. 
These results are also in line with research in RA. A randomized controlled trial investigating 
the effects of patient education about the benefits of improving lifestyle vs. standard care, 
demonstrated that the intentions and behaviors of the RA patients change beneficially, and 
importantly this can significantly reduce blood pressure, while such changes were not observed 
in the control group (83). Brief (3-4 minutes) healthcare practitioner-led advice on physical 
activity during routine patient visits (a) using specific guidelines and current national 
recommendations (76, 84) and after (b) adequate expert-developed e-Learning capacity 
building, could therefore help overcome one of the most important barriers within clinical 
practice, in order  to address the lack of physical activity implementation in the clinical care of 
RA.  
 
4.2 Addressing patients’ barriers for a sustainable increase in physical activity  
 
Incorporating advice about physical activity and reinforcing its importance with viable targets 
during routine clinical visits, therefore, is the first key step. In line with this, several different 
lines of evidence reveal that physical activity as part of the management of RA is very rarely 
discussed in routine face-to-face rheumatologist-patient visits (72) and the time allocated for 
such a discussion remains inadequate. Therefore, it is not surprising that RA patients still 
identify the lack of clarity and support for physical activity from their physicians/nurses as a 
main barrier to their participation (85). In contrast, receiving such information has been shown 
– in early qualitative studies - to associate with higher levels of physical activity engagement 
among RA patients (86). Moreover, a recent qualitative study revealed that patients require 
physical activity advice from their “trusted health professionals” in order to become more 
physically active but most importantly, to adhere to such a lifestyle (61, 62).  
In addition to the above, empowerment for RA patients from trusted healthcare professionals 
to develop their knowledge about the safety and effectiveness of physical activity is key, 
particularly to understand that their own main barriers – i.e. fear of exacerbating symptoms 
such as pain and fatigue and further worsening functional ability – can be significantly 
improved by exercising. Thus, if our first proposed step for the capacity building of healthcare 
professionals doesn’t take place, the improvement in knowledge/education of the patients about 
the beneficial mechanisms of physical activity in RA may be inadequate, the response 
effectiveness will lack specificity, thus, compromising long-term sustainability of the 
beneficial effects of physical activity.   
Importantly, another key factor to support a sustainable increase in physical activity in RA is 
via disruptive social innovation i.e. the empowerment of the communities (patient 
organizations, community groups, third sector, exercise professionals) to support either (a) 
physical activity referrals from healthcare practitioners or even (b) implement physical activity 
interventions for RA patients on their own. Capacity building of exercise professionals, patient 
volunteers and/or third sector organizations, via development of relevant workshops and 
seminars, in order to help them develop their knowledge on how to exercise RA patients is key 
for a sustainable implementation. For example, when exercise coaches and volunteers know 
how to develop individualized and safe exercise interventions for RA patients, which are 
incentivized and formally rewarded,  while at the same time offering a range of activities (e.g. 
dance, water-based activities, modified sports such as walking football, tai-chi etc.), is also an 
important factor for developing sustainable physical activity interventions. In the United States, 
a similar approach exists with the “exercise pharmacies” for patients with CVD, whereby 
healthcare professionals confidently refer patients with CVD to exercise professionals / 
community-build programs to improve their health outcomes (87). In such a way, RA patients 
can attend disease-specific physical activity RA referral schemes with a variation of physical 
activities which may further contribute to long-term sustainability. It is important to note, that 
this approach, addresses established patient-identified barriers for reduced physical activity and 
specifically the lack of: (a) RA specific physical activity programs and (b) knowledgeable 
exercise instructors (34).  
 
4.3 Physical activity advice in clinical practice and referral process 
 
A schematic representation of our healthcare practitioner-led implementation suggestion for 
the long-term sustainability of physical activity appears in Figure 2.  
 
Step 1: Patients with early RA or those with-long standing RA are currently best treated with 
a treat-to-target approach, based predominantly, if not exclusively, to semi-objective 
assessment of their disease activity. Irrespective of their current disease status, and alongside 
any decisions about the best possible pharmacological management, patients should be 
informed briefly during their routine visits, that implementing appropriate lifestyle 
modifications, including becoming more physically active, is also important and will be needed 
for effective long-term management. This first introduction of the role of physical activity 
should be consistently re-inforced by all rheumatology health professionals in every 
subsequent visit. Once the inflammatory component of the disease is sufficiently controlled, 
patients should be motivated to engage in physical activity with specific targets agreed with 
them (e.g. increase steps / week, see Figure 2). A first viable and easy way to achieve this is 
by increasing walking time, a mode that improves significantly health outcomes (88). Current 
suggestions for public health suggest walking 10.000 step / day, with 3.000 step / day equating 
to approximately 30 min of moderate physical activity (89). As a first step to increase physical 
activity, this information can briefly be provided/prescribed within clinical practice by the 
managing rheumatologist and re-inforced consistently by all members of the rheumatology 
multidisciplinary care team. Altrnatively, based on their current physical activity levels 
(minutes or steps / week), physically inactive patients should be motivated to progressively 
reach the recommended levels of physical activity levels equating to 150 minutes / week (rather 
than step / day, as per the previous example). Targets to reach the recommended physical 
activity should be based on current levels and be re-visited and revised in every routine patient 
visit. Not achieving previously agreed targets should be briefly discussed, and healthcare 
professionals should try to further motivate patients to reach their targets by their next routine 
visit. However, it is important to note that the current established public health 
recommendations suggest 150 min / week of moderate to vigorous physical activity, combined 
with resistance training twice a week. Implementation of these recommendations, is likely to 
exceed the knowledge, competence and even time-availability of rheumatology healthcare 
professionals, so once step targets are reached, onwards referral to exercise physiologists could 
be considered.  
 
Step 2: Empowerment of RA patients to understand that physical activity is key for their long-
term management is also necessary. This advice can also be brief and should always be 
accompanied by ensuring patients, that physical activity is (a) safe and (b) can improve the 
main RA symptoms that may currently inhibit their participation in physical activity (i.e. 
functional disability, pain and fatigue).  
In addition to the above approach, patient-centered approaches could also facilitate 
implementation. Such an initiative has been developed recently by the most prominent 
organization for RA patients in the UK, the National Rheumatoid Arthritis Society (NRAS). 
This is a freely available online interactive e-program developed by patients themselves, 
facilitated by experts, and aims to help RA patients set specific goals in order to self-manage 
risks related to their condition as well as mitigate their CVD risk (e.g. adherence to medication, 
increasing physical activity and improving diet). The program is firmly based on research work 
that has been progressively developed over many years by a collaboration of patients, 
rheumatology health professionals, exercise physiologists, behavioural scientists and 
educationalists aiming to implement lifestyle interventions to reduce CVD risk in peiople with 
RA (77). However, its effectiveness and reach remain to be formally evaluated.    
 
Step 3: Capacity building of communities (e.g. exercise and sports coaches, patient volunteers, 
exercise instructors in local gyms) that can support physical activity is also necessary, albeit 
this is a public health rather a healthcare matter. Developing knowledge on how to exercise 
people with RA and incentivizing physical activity professionals (gym instructors, sports 
coaches, physical activity community groups) with relevant awards, will help develop a body 
of professionals that will be able to help RA patients exercise safely and progressively in order 
to achieve improvements in disease symptoms as well as overall health benefits. The purpose 
of these initiatives, which has to be reinforced by the managing healthcare practitioners during 
routine visits, has to be the aforementioned specific recommended targets of 150 min /week 
(moderate to vigorous intensity with the addition of resistance training) in order to optimize 
the healthcare management of RA patients. A single, clear, simple and consistent message 
reinforced by all involved in an RA patient’s care pathway (from community to primary and 
secondary care and beyond) is essential for future change.  
 
  




Increasing physical activity and/or exercise can beneficially and simultaneously impact 
beneficially on different disease-related symptoms and systemic manifestations of RA. 
However, implementing physical activity in routine practice has always been a challenge for 
healthcare practitioners due to unfounded patient-specific barriers, lack of understanding or 
misconceptions of health practitioners as well as lack of relevant infrastructure and provision. 
Implementation of physical activity in clinical practice can be led, in a pragmatic manner, by 
rheumatology healthcare practitioners during routine patient visits and supported by social 
innovation. The main constituents of an implementation model are proposed based on current 
evidence and expert opinion, but its effectiveness and cost-effectiveness should be tested in 
appropriately designed trials.  
 
Research Agenda 
 More methodologically robust studies are required to understand the effects of physical 
activity on different physiological mechanisms in RA, including inflammatory, cardiac 
and inflammatory responses 
 Research is currently required to better undertstand how to implement physical activity 
in clinical rac tice, given the multiple beneficial effects of physical activity on RA 
clinically- and patient-important outcomes   
Confict of interests statement 
The authors disclose that they do not have any conficts of interest 
 
Funding Statement 
The authors did not receive funding for this narrative review 
References 
 
1. Walsmith J, Roubenoff R. Cachexia in rheumatoid arthritis. Int J Cardiol 
2002;85(1):89-99. 
2. NRAS. National Rheumatoid Arthritis Society. The Economic Burben of Reumatoid 
Arthritis. 2010. 
3. Chaudhari P. The impact of rheumatoid arthritis and biologics on employers and payers. 
Biotechnol Healthc 2008;5(2):37-44. 
4. Metsios GS, Stavropoulos-Kalinoglou A, Treharne GJ, Nevill AM, Sandoo A, Panoulas 
VF, et al. Disease activity and low physical activity associate with number of hospital 
admissions and length of hospitalisation in patients with rheumatoid arthritis. Arthritis Res 
Ther 2011;13(3):R108. 
5. Oldridge N. Exercise-based cardiac rehabilitation in patients with coronary heart 
disease: meta-analysis outcomes revisited. Future Cardiol 2012;8(5):729-51. 
6. Hurkmans E, van der Giesen FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC. 
Dynamic exercise programs (aerobic capacity and/or muscle strength training) in patients with 
rheumatoid arthritis. Cochrane Database Syst Rev 2009(4):CD006853. 
7. Van Den Ende CH, Vliet Vlieland TP, Munneke M, Hazes JM. Dynamic exercise 
therapy for rheumatoid arthritis. Cochrane Database Syst Rev 2000(2):CD000322. 
8. Baillet A, Vaillant M, Guinot M, Juvin R, Gaudin P. Efficacy of resistance exercises in 
rheumatoid arthritis: meta-analysis of randomized controlled trials. Rheumatology (Oxford) 
2012;51(3):519-27. 
9. Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJ, Treharne GJ, 
Panoulas VF, Douglas KM, et al. Rheumatoid arthritis, cardiovascular disease and physical 
exercise: a systematic review. Rheumatology (Oxford) 2008;47(3):239-48. 
10. Rongen-van Dartel SA, Repping-Wuts H, Flendrie M, Bleijenberg G, Metsios GS, van 
den Hout WB, et al. Effect of Aerobic Exercise Training on Fatigue in Rheumatoid Arthritis: 
A Meta-Analysis. Arthritis Care Res (Hoboken) 2015;67(8):1054-62. 
11. de Jong Z, Munneke M, Zwinderman AH, Kroon HM, Jansen A, Ronday KH, et al. Is 
a long-term high-intensity exercise program effective and safe in patients with rheumatoid 
arthritis? Results of a randomized controlled trial. Arthritis Rheum 2003;48(9):2415-24. 
12. Munneke M, de Jong Z, Zwinderman AH, Ronday HK, van Schaardenburg D, 
Dijkmans BA, et al. Effect of a high-intensity weight-bearing exercise program on radiologic 
damage progression of the large joints in subgroups of patients with rheumatoid arthritis. 
Arthritis Rheum 2005;53(3):410-7. 
13. Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJ, Nightingale P, 
Sandoo A, Dimitroulas T, et al. Individualised exercise improves endothelial function in 
patients with rheumatoid arthritis. Ann Rheum Dis 2014;73(4):748-51. 
14. Stavropoulos-Kalinoglou A, Metsios GS, Veldhuijzen van Zanten JJ, Nightingale P, 
Kitas GD, Koutedakis Y. Individualised aerobic and resistance exercise training improves 
cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis. 
Ann Rheum Dis 2013;72(11):1819-25. 
15. Lemmey AB, Marcora SM, Chester K, Wilson S, Casanova F, Maddison PJ. Effects of 
high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled 
trial. Arthritis Rheum 2009;61(12):1726-34. 
16. Lemmey AB, Wilkinson TJ, Clayton RJ, Sheikh F, Whale J, Jones HS, et al. Tight 
control of disease activity fails to improve body composition or physical function in 
rheumatoid arthritis patients. Rheumatology (Oxford) 2016;55(10):1736-45. 
17. Summers GD, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. Rheumatoid 
cachexia and cardiovascular disease. Nat Rev Rheumatol 2010;6(8):445-51. 
18. Metsios GS, Lemmey A. Exercise as Medicine in Rheumatoid Arthritis: Effects on 
Function, Body Composition, and Cardiovascular Disease Risk. Journal of Clinical Exercise 
Physiology 2015;4(1):14-22. 
19. Fenton SAM, Sandoo A, Metsios GS, Duda JL, Kitas GD, Veldhuijzen van Zanten J. 
Sitting time is negatively related to microvascular endothelium-dependent function in 
rheumatoid arthritis. Microvasc Res 2018;117:57-60. 
20. Fenton SAM, Veldhuijzen van Zanten J, Duda JL, Metsios GS, Kitas GD. Sedentary 
behaviour in rheumatoid arthritis: definition, measurement and implications for health. 
Rheumatology (Oxford) 2018;57(2):213-26. 
21. Fenton SAM, Veldhuijzen van Zanten J, Kitas GD, Duda JL, Rouse PC, Yu CA, et al. 
Sedentary behaviour is associated with increased long-term cardiovascular risk in patients with 
rheumatoid arthritis independently of moderate-to-vigorous physical activity. BMC 
Musculoskelet Disord 2017;18(1):131. 
22. Tierney M, Fraser A, Kennedy N. Physical activity in rheumatoid arthritis: a systematic 
review. J Phys Act Health 2012;9(7):1036-48. 
23. Blair SN. Physical inactivity: the biggest public health problem of the 21st century. Br 
J Sports Med 2009;43(1):1-2. 
24. Metsios GS, Koutedakis Y, Veldhuijzen van Zanten JJ, Stavropoulos-Kalinoglou A, 
Vitalis P, Duda JL, et al. Cardiorespiratory fitness levels and their association with 
cardiovascular profile in patients with rheumatoid arthritis: a cross-sectional study. 
Rheumatology (Oxford) 2015;54(12):2215-20. 
25. Benatti FB, Pedersen BK. Exercise as an anti-inflammatory therapy for rheumatic 
diseases-myokine regulation. Nat Rev Rheumatol 2015;11(2):86-97. 
26. Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived 
interleukin-6. Physiol Rev 2008;88(4):1379-406. 
27. Munoz-Canoves P, Scheele C, Pedersen BK, Serrano AL. Interleukin-6 myokine 
signaling in skeletal muscle: a double-edged sword? FEBS J 2013;280(17):4131-48. 
28. Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic 
disease. J Clin Invest 2017;127(1):1-4. 
29. Verheggen RJ, Maessen MF, Green DJ, Hermus AR, Hopman MT, Thijssen DH. A 
systematic review and meta-analysis on the effects of exercise training versus hypocaloric diet: 
distinct effects on body weight and visceral adipose tissue. Obes Rev 2016;17(8):664-90. 
30. Hayashino Y, Jackson JL, Hirata T, Fukumori N, Nakamura F, Fukuhara S, et al. 
Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with 
type 2 diabetes: a meta-analysis of randomized controlled trials. Metabolism 2014;63(3):431-
40. 
31. Hakkinen A, Sokka T, Kotaniemi A, Hannonen P. A randomized two-year study of the 
effects of dynamic strength training on muscle strength, disease activity, functional capacity, 
and bone mineral density in early rheumatoid arthritis. Arthritis Rheum 2001;44(3):515-22. 
32. Hagen KB, Dagfinrud H, Moe RH, Osteras N, Kjeken I, Grotle M, et al. Exercise 
therapy for bone and muscle health: an overview of systematic reviews. BMC Med 
2012;10:167. 
33. Silva KN, Mizusaki Imoto A, Almeida GJ, Atallah AN, Peccin MS, Fernandes Moca 
Trevisani V. Balance training (proprioceptive training) for patients with rheumatoid arthritis. 
Cochrane Database Syst Rev 2010(5):CD007648. 
34. Veldhuijzen van Zanten JJ, Rouse PC, Hale ED, Ntoumanis N, Metsios GS, Duda JL, 
et al. Perceived Barriers, Facilitators and Benefits for Regular Physical Activity and Exercise 
in Patients with Rheumatoid Arthritis: A Review of the Literature. Sports Med 
2015;45(10):1401-12. 
35. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, et al. EULAR 
recommendations for cardiovascular disease risk management in patients with rheumatoid 
arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 
2017;76(1):17-28. 
36. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. 
Physiol Rev 2013;93(3):993-1017. 
37. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane 
Database Syst Rev 2006(3):CD002968. 
38. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, Wilson M, Nevill AM, 
Koutedakis Y, et al. Association of physical inactivity with increased cardiovascular risk in 
patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil 2009;16(2):188-94. 
39. Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Nightingale P, Koutedakis Y, 
Kitas GD. Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-
weight but not in obese patients with rheumatoid arthritis. Arthritis Res Ther 2012;14(4):R160. 
40. Stavropoulos-Kalinoglou A, Metsios GS, Panoulas VF, Douglas KM, Nevill AM, 
Jamurtas AZ, et al. Associations of obesity with modifiable risk factors for the development of 
cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 2009;68(2):242-
5. 
41. Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review 
and meta-analysis. J Am Heart Assoc 2013;2(1):e004473. 
42. Hamer M. The anti-hypertensive effects of exercise: integrating acute and chronic 
mechanisms. Sports Med 2006;36(2):109-16. 
43. Calabresi L, Franceschini G. Lecithin:cholesterol acyltransferase, high-density 
lipoproteins, and atheroprotection in humans. Trends Cardiovasc Med 2010;20(2):50-3. 
44. Ferguson MA, Alderson NL, Trost SG, Essig DA, Burke JR, Durstine JL. Effects of 
four different single exercise sessions on lipids, lipoproteins, and lipoprotein lipase. J Appl 
Physiol (1985) 1998;85(3):1169-74. 
45. Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance 
training and combined exercise modalities on cholesterol and the lipid profile: review, 
synthesis and recommendations. Sports Med 2014;44(2):211-21. 
46. Kelley GA, Kelley KS. Aerobic exercise and lipids and lipoproteins in men: a meta-
analysis of randomized controlled trials. J Mens Health Gend 2006;3(1):61-70. 
47. Kelley GA, Kelley KS, Tran ZV. Aerobic exercise and lipids and lipoproteins in 
women: a meta-analysis of randomized controlled trials. J Womens Health (Larchmt) 
2004;13(10):1148-64. 
48. Duggan C, Tapsoba JD, Wang CY, Campbell KL, Foster-Schubert K, Gross MD, et al. 
Dietary Weight Loss, Exercise, and Oxidative Stress in Postmenopausal Women: A 
Randomized Controlled Trial. Cancer Prev Res (Phila) 2016;9(11):835-43. 
49. Wadley AJ, Veldhuijzen van Zanten JJ, Stavropoulos-Kalinoglou A, Metsios GS, 
Smith JP, Kitas GD, et al. Three months of moderate-intensity exercise reduced plasma 3-
nitrotyrosine in rheumatoid arthritis patients. Eur J Appl Physiol 2014;114(7):1483-92. 
50. Sandoo A, Veldhuijzen van Zanten JJ, Metsios GS, Carroll D, Kitas GD. Vascular 
function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 
2011;50(11):2125-39. 
51. Metsios GS, Stavropoulos-Kalinoglou A, Sandoo A, van Zanten JJ, Toms TE, John H, 
et al. Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. 
Open Cardiovasc Med J 2010;4:89-96. 
52. Gould DW, Lahart I, Carmichael AR, Koutedakis Y, Metsios GS. Cancer cachexia 
prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle 
2013;4(2):111-24. 
53. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, Koutedakis Y, Nevill AM, 
Douglas KM, et al. New resting energy expenditure prediction equations for patients with 
rheumatoid arthritis. Rheumatology (Oxford) 2008;47(4):500-6. 
54. Metsios GS, Stavropoulos-Kalinoglou A, Nevill AM, Douglas KM, Koutedakis Y, 
Kitas GD. Cigarette smoking significantly increases basal metabolic rate in patients with 
rheumatoid arthritis. Ann Rheum Dis 2008;67(1):70-3. 
55. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, Nevill AM, Douglas KM, 
Jamurtas A, et al. Redefining overweight and obesity in rheumatoid arthritis patients. Ann 
Rheum Dis 2007;66(10):1316-21. 
56. Metsios GS, Stavropoulos-Kalinoglou A, Panoulas VF, Sandoo A, Toms TE, Nevill 
AM, et al. Rheumatoid cachexia and cardiovascular disease. Clin Exp Rheumatol 
2009;27(6):985-8. 
57. Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ. Randomized phase 2 
trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid 
arthritis. Am J Clin Nutr 2006;84(6):1463-72. 
58. Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, Koutedakis Y, Nevill AM, 
Panoulas VF, et al. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects 
on components of rheumatoid cachexia. Rheumatology (Oxford) 2007;46(12):1824-7. 
59. Baillet A, Zeboulon N, Gossec L, Combescure C, Bodin LA, Juvin R, et al. Efficacy of 
cardiorespiratory aerobic exercise in rheumatoid arthritis: meta-analysis of randomized 
controlled trials. Arthritis Care Res (Hoboken) 2010;62(7):984-92. 
60. Sokka T, Hakkinen A, Kautiainen H, Maillefert JF, Toloza S, Mork Hansen T, et al. 
Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a 
cross-sectional, international study. Arthritis Rheum 2008;59(1):42-50. 
61. Withall J, Haase AM, Walsh NE, Young A, Cramp F. Physical activity engagement in 
early rheumatoid arthritis: a qualitative study to inform intervention development. 
Physiotherapy 2015. 
62. Larkin L, Kennedy N, Fraser A, Gallagher S. ‘It might hurt, but still it’s good’: People 
with rheumatoid arthritis beliefs and expectations about physical activity interventions. DOI: 
10.1177/1359105316633286 Journal of Health Psychology 2016:1-13. 
63. Larkin L, Gallagher S, Cramp F, Brand C, Fraser A, Kennedy N. Behaviour change 
interventions to promote physical activity in rheumatoid arthritis: a systematic review. 
Rheumatol Int 2015;35(10):1631-40. 
64. Rouse PC, Veldhuijzen Van Zanten JJ, Metsios GS, Ntoumanis N, Yu CA, Koutedakis 
Y, et al. Fostering autonomous motivation, physical activity and cardiorespiratory fitness in 
rheumatoid arthritis: protocol and rationale for a randomised control trial. BMC Musculoskelet 
Disord 2014;15:445. 
65. Dalal HM, Doherty P, Taylor RS. Cardiac rehabilitation. BMJ 2015;351:h5000. 
66. Doyle C, Lennox L, Bell D. A systematic review of evidence on the links between 
patient experience and clinical safety and effectiveness. BMJ Open 2013;3(1). 
67. Ong LM, de Haes JC, Hoos AM, Lammes FB. Doctor-patient communication: a review 
of the literature. Soc Sci Med 1995;40(7):903-18. 
68. Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. The role of exercise in the 
management of rheumatoid arthritis. Expert Rev Clin Immunol 2015;11(10):1121-30. 
69. Metsios GS, Lahart IM. Exercise as medicine in rheumatoid arthritis. Mediterr J 
Rheumatol 2015;26(2):54-61. 
70. W.H.O. World Health Organisation. Factsheet No 385. Global Recommendations of 
Physical Activity and Health. http://www.who.int/dietphysicalactivity/pa/en/. 2015. 
71. Kislov R, Waterman H, Harvey G, Boaden R. Rethinking capacity building for 
knowledge mobilisation: developing multilevel capabilities in healthcare organisations. 
Implement Sci 2014;9:166. 
72. Iversen MD, Fossel AH, Daltroy LH. Rheumatologist-patient communication about 
exercise and physical therapy in the management of rheumatoid arthritis. Arthritis Care Res 
1999;12(3):180-92. 
73. Halls S, Law RJ, Jones JG, Markland DA, Maddison PJ, Thom JM. Health 
Professionals' Perceptions of the Effects of Exercise on Joint Health in Rheumatoid Arthritis 
Patients. Musculoskeletal Care 2016. 
74. Rashid S, Jamall OA, Iqbal S, Rizvi AF, Nayeem O, Khan AM. The clinical relevance 
of physical activity education in medical school. Med Educ Online 2016;21:30693. 
75. Cook DA, Levinson AJ, Garside S, Dupras DM, Erwin PJ, Montori VM. Internet-based 
learning in the health professions: a meta-analysis. JAMA 2008;300(10):1181-96. 
76. Berra K, Rippe J, Manson JE. Making Physical Activity Counseling a Priority in 
Clinical Practice: The Time for Action Is Now. JAMA 2015;314(24):2617-8. 
77. Writing Group for the Activity Counseling Trial Research G. Effects of physical 
activity counseling in primary care: the Activity Counseling Trial: a randomized controlled 
trial. JAMA 2001;286(6):677-87. 
78. Maruthur NM, Wang NY, Appel LJ. Lifestyle interventions reduce coronary heart 
disease risk: results from the PREMIER Trial. Circulation 2009;119(15):2026-31. 
79. Dasgupta K, Rosenberg E, Joseph L, Cooke AB, Trudeau L, Bacon SL, et al. Physician 
Step prescription and Monitoring to improve ARTERial health (SMARTER): a randomized 
controlled trial in type 2 diabetes and hypertension. Diabetes Obes Metab 2017. 
80. Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, 
Kita MD, et al. Prevalence and associations of hypertension and its control in patients with 
rheumatoid arthritis. Rheumatology (Oxford) 2007;46(9):1477-82. 
81. Panoulas VF, Metsios GS, Pace AV, John H, Treharne GJ, Banks MJ, et al. 
Hypertension in rheumatoid arthritis. Rheumatology (Oxford) 2008;47(9):1286-98. 
82. Dessein PH, Joffe BI. Insulin resistance and impaired beta cell function in rheumatoid 
arthritis. Arthritis Rheum 2006;54(9):2765-75. 
83. John H, Hale ED, Treharne GJ, Kitas GD, Carroll D. A randomized controlled trial of 
a cognitive behavioural patient education intervention vs a traditional information leaflet to 
address the cardiovascular aspects of rheumatoid disease. Rheumatology (Oxford) 
2013;52(1):81-90. 
84. N.I.C.E. National Institute of Health and Care Excellence. Physical activity: exercise 
referral schemes. https://www.nice.org.uk/guidance/ph54. 2014. 
85. Wilcox S, Der Ananian C, Abbott J, Vrazel J, Ramsey C, Sharpe PA, et al. Perceived 
exercise barriers, enablers, and benefits among exercising and nonexercising adults with 
arthritis: results from a qualitative study. Arthritis Rheum 2006;55(4):616-27. 
86. Terpstra SJ, de Witte LP, Diederiks JP. Compliance of patients with an exercise 
program for rheumatoid arthritis. Physiother Can 1992;44:37-41. 
87. ACSM. A Landmark Accomplishment for ACSM & Exercise is Medicine® (EIM) – 
Implementing the EIM Solution http://www.acsm.org/public-information/acsm-
blog/2016/03/23/a-landmark-accomplishment-for-acsm-exercise-is-medicine-(eim)-
implementing-the-eim-solution2016. 
88. Murtagh EM, Nichols L, Mohammed MA, Holder R, Nevill AM, Murphy MH. The 
effect of walking on risk factors for cardiovascular disease: an updated systematic review and 
meta-analysis of randomised control trials. Prev Med 2015;72:34-43. 
89. Marshall S, J.,, Levy S, S.,, Tudor-Locke C, E.,, Kolkhorst F, W.,, Wooten K, M.,, Ji 
M, et al. Translating physical activity recommendations into a pedometer-based step goal: 3000 
steps in 30 minutes. Am J Prev Med 2009;36(5):410-5. 
 
